Knowledge centre

Filter by

Recent posts

Webinar – Overcoming the challenges of plasmid DNA in AAV manufacturing
Webinar – Overcoming the challenges of plasmid DNA in AAV manufacturing
Read Article
White Paper – The future of Industrial Scale Lentiviral Vector Manufacturing
White Paper – The future of Industrial Scale Lentiviral Vector Manufacturing
Read Article
Article – Antibiotics in biopharmaceutical production
Article – Antibiotics in biopharmaceutical production
Read Article
Webinar – Strategies for commercialising a novel enzymatic DNA technology
Webinar – Strategies for commercialising a novel enzymatic DNA technology
Read Article
Info sheet – Enzymatic DNA  for mRNA production
Info sheet – Enzymatic DNA for mRNA production
Download
Nature Gene Therapy – Enzymatically amplified linear dbDNA as a rapid and scalable solution to lentiviral vector manufacturing
Nature Gene Therapy – Enzymatically amplified linear dbDNA as a rapid and scalable solution to lentiviral vector manufacturing
Read Article
Webinar – Resolving the challenges of plasmid DNA in mRNA manufacturing
Webinar – Resolving the challenges of plasmid DNA in mRNA manufacturing
Read Article
Endpoints News – Months after big financing round, Touchlight signs supply agreement for Versameb’s pipeline
Endpoints News – Months after big financing round, Touchlight signs supply agreement for Versameb’s pipeline
Read more
Drug Discovery Today – dbDNA™ an advanced platform for genetic medicines
Drug Discovery Today – dbDNA™ an advanced platform for genetic medicines
Read Article
Webinar – Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
Webinar – Overcoming Plasmid DNA Limitations in Advanced Therapy Manufacturing
Read Article
Molecular Therapy – Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
Molecular Therapy – Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
Read Article
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Nature Biopharma Dealmakers: Reshaping the production of DNA-based therapies
Read more